Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: direct delivery investigational medicine

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience

Posted on May 15, 2025 digi By digi

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience Bringing Clinical Trials Home: Direct-to-Patient Drug Delivery for Modern Research Direct-to-Patient (DTP) drug delivery has become a pivotal innovation in decentralized and hybrid clinical trials, enabling investigational products (IP) to reach participants directly at their homes. By minimizing site visits and enhancing patient convenience, DTP…

Read More “Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience” »

Decentralized Clinical Trials (DCTs), Direct-to-Patient Drug Delivery

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Adherence and Compliance Studies in Phase 4 Clinical Trials: Real-World Challenges and Strategies
  • Post-Approval Commitments and Phase 4 Study Planning After Phase 3 Trials: A Complete Guide
  • Sample Size Calculation for Phase 2 Trials
  • Phase 1 Studies for Biosimilars: PK, PD, and Immunogenicity Assessment
  • Economic Outcomes and Cost-Effectiveness in Phase 4 Clinical Trials

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme